T
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K702.1 KBTobira Therapeutics, Inc.Sep 20, 9:23 AM ET·0001193125-16-714192
- 38.5 KBTobira Therapeutics, Inc.Dec 18, 12:12 PM ET·0000904454-15-000784
- 8-K21.7 KBTobira Therapeutics, Inc.Jul 14, 8:32 PM ET·0001193125-15-252629
- 8-K31.7 KBTobira Therapeutics, Inc.Jun 8, 4:31 PM ET·0001193125-15-216400
- 48.7 KBRegado Biosciences IncJan 6, 9:54 AM ET·0001209191-15-001777
- 45.3 KBRegado Biosciences IncJan 5, 6:19 PM ET·0001209191-15-001389
- 48.3 KBRegado Biosciences IncJan 5, 6:17 PM ET·0001209191-15-001377
- 48.5 KBRegado Biosciences IncJan 5, 6:16 PM ET·0001209191-15-001372
- 48.5 KBRegado Biosciences IncJan 5, 6:16 PM ET·0001209191-15-001367
- 45.5 KBRegado Biosciences IncJan 5, 6:15 PM ET·0001209191-15-001362
Insiders
9Tickers
No tickers on record
Addresses
business
701 GATEWAY BLVD SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
701 GATEWAY BLVD SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Tibira Therapeutics, Inc.2015-05-06
- Regado Biosciences Inc2015-05-06